This site is intended for healthcare professionals only
LoginRegister
Eli Lilly Jaypirca met its primary endpoint in head-to-head Phase 3 study versus ImbruvicaEli Lilly Inluriyo gets USFDA nod for adults with advanced breast cancer
Dr Reddys Labs appoints Gayatri Prabhu as Head Digital Marketing (Emerging Markets)Dr Reddy's Labs appoints Gayatri Prabhu as Head Digital Marketing (Emerging Markets)
Alkem Labs Senior Management Personnel Amit Ghare steps downAlkem Labs Senior Management Personnel Amit Ghare steps down
After DEG Contamination Scare, CDSCO Launches ONDLS Digital Monitoring System for High-Risk SolventsCDSCO Tightens RTI Appeal Timelines, Division Heads to Face Penalties for Lapses
Odisha launches Pharmaceutical and Medical Devices Policy 2025, eyes Rs 25000 cr investmentTata 1mg in Advanced Talks to Raise USD 200 Million, Valuation Standoff Emerges
Inside Coldrif Scandal: Tamil Nadu Plant Used Paint-Grade Chemicals, Violated 300+ Drug NormsPatna HC Denies Bail in Codeine Syrup Case: Possession Below 2.5% Still NDPS Offence
Alembic Pharma wins USFDA nod for heart disease drugAlembic Pharma Gets USFDA Nod for Generic Paxil CR Tablets
Cybercriminals Trick Dr Reddys Finance Team, Divert Rs 2.16 Crore PaymentGame-Changer for HIV: Dr Reddy's, Hetero to Sell Generic Lenacapavir at Rs 3,547 a Year
Sanofi gets approval for 2 rare hematologic diseases medicines in ChinaSanofi Commits USD 625 Million to Sanofi Ventures to Boost Biotech and Digital Health Startups
Govt Sanctions Rs 181.59 Cr for Pharma Upgrades Under RPTUS, Parliament InformedSyneos Health Asked to Clarify Phase II Tacrolimus Trial Protocol by CDSCO Panel
Pharmacy Student from Bihar Goes Missing in Lucknows Banthra, Search UnderwayPharmacy Student from Bihar Goes Missing in Lucknow's Banthra, Search Underway
Zydus-owned Sentynls Menkes disease drug NDA resubmission accepted by USFDAZydus Lifesciences Gets CDSCO Panel Nod for Bioavailability Study of Antimalarial Candidate ZY-19489
X